Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Urban Health
Published in: Journal of Urban Health 1/2018

01-02-2018 | Editorial

Preventing Injection Drug use Initiation: State of the Evidence and Opportunities for the Future

Authors: Dan Werb, R. N. Bluthenthal, G. Kolla, C. Strike, A. H. Kral, A. Uusküla, D. Des Jarlais

Published in: Journal of Urban Health | Issue 1/2018

Login to get access

Excerpt

Just over 10 years have passed since public health experts called for an update to the “infection risk reduction hierarchy” [1]. At the time Vlahov et al. noted that HIV prevention programs for people who inject drugs (PWID), 13% of whom are estimated to be HIV positive [2], should include referral to addiction treatment, increased access to sterile syringes, and education regarding the harms of syringe sharing, given that all had been proven effective at reducing the spread of injection-related HIV transmission [1]. However, while these interventions are critical to reducing the burden of HIV faced by active injectors, they also argued that the most effective method of preventing injection-driven HIV epidemics was to shift resources upstream, towards the prevention of injection drug use itself [1]. Since the publication of this commentary, expanded coverage of harm reduction services and the provision of sterile injecting equipment have resulted in reductions in HIV transmission among PWID in select settings. However, blood-borne disease epidemics continue to expand among PWID populations; for example, according to UNAIDS, HIV infections among PWID increased by 33% globally between 2011 and 2014 [3]. Concurrently, fatal drug overdose (often related to opioid injecting) has become a leading cause of death in both the USA and Canada [4‐6]. We therefore seek to assess the state of the science on the prevention of injection initiation, to identify emerging interventional strategies, and to consider the barriers that remain in effectively controlling ongoing epidemics of injection drug use. …
Literature
1.
Vlahov D, Fuller CM, Ompad DC, Galea S, Des Jarlais DC. Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health. 2004;81(1):14.CrossRefPubMedPubMedCentral
2.
UNAIDS. The Gap report. Geneva: Joint United Nations Programme on HIV/AIDS; 2014.
3.
4.
Katz J. Drug deaths in America are rising faster than ever. The New York Times 2017.
5.
Proctor J, Larsen K. ‘An exceptionally high toll’: fentanyl, overdoses claim 488 in B.C. CBCca. CBC/Radio-Canada: Toronto, ON. 2016
6.
Gomes T, Mamdani MM, Dhalla IA, Cornish S, Paterson JM, Juurlink DN. The burden of premature opioid-related mortality. Addiction. 2014;109(9):1482–8.CrossRefPubMedPubMedCentral
7.
Casriel C, Rockwell R, Stepherson B. Heroin sniffers: between two worlds. J Psychoactive Drugs. 1988;20(4):437–40.CrossRefPubMed
8.
Casriel C, Des Jarlais DC, Rodriguez R, Friedman SR, Stepherson B, Khuri E. Working with heroin sniffers: clinical issues in preventing drug injection. J Subst Abus Treat. 1990;7(1):1–10.CrossRef
9.
Des Jarlais CD, Casriel C, Friedman SR, Rosenblum A. AIDS and the transition to illicit drug injection: results of a randomized trial prevention program. Br J Addict. 1992;87(3):6.
10.
Hunt N, Stillwell G, Taylor C, Griffiths P. Evaluation of a brief intervention to prevent initiation into injecting. Drug Educ Prev Policy. 1998;5(2):185–94.CrossRef
11.
Hunt PG. Mathew Southwell, Garry Stillwell, John Strang, Neil. Preventing and curtailing injecting drug use: a review of opportunities for developing and delivering'route transition interventions. Drug Alcohol Rev. 1999;18(4):441–51.CrossRef
12.
Roy E, Haley N, Leclerc P, Cedras L, Boivin JF. Drug injection among street youth: the first time. Addiction. 2001;97:1003–9.CrossRef
13.
Roy E, Haley N, Leclerc P, Cedras L, Blais L, Boivin JF. Drug injection among street youths in Montreal: predictors of initiation. J Urban Health. 2003;80(1):92.
14.
Wood E, Stolz J-A, Montaner JISG, Kerr T. Evaluating methamphetamine use and risks of injection initiation among street youth: The ARYS study. Harm Reduct J. 2006;3(18):1.
15.
Bridge J. Route transition interventions: potential public health gains from reducing or preventing injecting. Int J Drug Policy. 2010;21(2):125–8.CrossRefPubMed
16.
Kral A, Wenger L, Chu D, et al. Initiating people into illicit drug injection. Drug Alcohol Depend. 2015;146:e164.CrossRef
17.
Bluthenthal RN, Wenger L, Chu D, et al. Factors associated with being asked to initiate someone into injection drug use. Drug Alcohol Depend. 2015;149:252–8.CrossRefPubMedPubMedCentral
18.
Werb D, Buxton J, Shoveller J, Richardson C, Rowell G, Wood E. Interventions to prevent the initiation of injection drug use: a systematic review. Drug Alcohol Depend. 2013;133(2):669–76.CrossRefPubMed
19.
Strike C, Rotondi M, Kolla G, et al. Interrupting the social processes linked with initiation of injection drug use: results from a pilot study. Drug Alcohol Depend. 2014;137:48–54.CrossRefPubMed
20.
Bluthenthal RN, Kral AH. Next steps in research on injection initiation incidence and prevention. Addiction. 2015;110(8):1258–9.CrossRefPubMed
21.
Werb D, Garfein R, Kerr T, et al. A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study. Harm Reduct J. 2016;13:25.CrossRefPubMedPubMedCentral
22.
Hadland SE, Werb D, Kerr T, et al. Childhood sexual abuse and risk for initiating injection drug use during adolescence and young adulthood: a prospective cohort study. J Adolesc Health. 2012;50(2):S1.CrossRef
23.
Young AM, Havens JR. Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis. Addiction. 2012;107(3):587–96.CrossRefPubMed
24.
Werb D, Kerr T, Buxton J, et al. Crystal methamphetamine and injecting initiation among street-involved youth in a Canadian setting. CMAJ. 2013;185(18):1569–75.CrossRefPubMedPubMedCentral
25.
Trenz RC, Scherer M, Harrell P, Zur J, Sinha A, Latimer W. Early onset of drug and polysubstance use as predictors of injection drug use among adult drug users. Addict Behav. 2012;37(4):367–72.CrossRefPubMed
26.
Strathdee SA, Zafar T, Brahmbhatt H, Baksh A, ul Hassan S. Rise in needle sharing among injection drug users in Pakistan during the Afghanistan war. Drug Alcohol Depend. 2003;71(1):17.CrossRefPubMed
27.
Guise A, Dimova M, Ndimbii J, Clark P, Rhodes T. A qualitative analysis of transitions to heroin injection in Kenya: implications for HIV prevention and harm reduction. Harm Reduct J. 2015;12(1):27.CrossRefPubMedPubMedCentral
28.
Harocopos A, Goldsamt LA, Kobrak P, Jost JJ, Clatts MC. New injectors and the social context of injection initiation. Int J Drug Policy. 2009;20(4):317–23.CrossRefPubMed
29.
Kermode M, Longleng V, Singh BC, Bowen K, Rintoul A. Killing time with enjoyment: a qualitative study of initiation into injecting drug use in north-east India. Subst Use Misuse. 2009;44(8):1070–89.CrossRefPubMed
30.
Khobzi N, Strike C, Cavalieri W, et al. A qualitative study on the initiation into injection drug use: necessary and background processes. Addict Res Theory. 2009;17(5):546–59.CrossRef
31.
Dertadian GC, Maher L. From oxycodone to heroin: two cases of transitioning opioid use in young Australians. Drug Alcohol Rev. 2014;33(1):102–4.CrossRefPubMed
32.
Feng C, DeBeck K, Kerr T, Mathias S, Montaner J, Wood E. Homelessness independently predicts injection drug use initiation among street-involved youth in a Canadian setting. J Adolesc Health. 2013;52(4):499–501.CrossRefPubMed
33.
Sotheran JL, Goldsmith DS, Blasco M, Friedman SR. Heroin sniffing as self-regulation among injecting and non-injecting heroin users. J Drug Issues. 1999;29(2):401–21.CrossRef
34.
Neaigus A, Atillasoy A, Friedman SR, et al. Trends in the noninjected use of heroin and factors associated with the transition to injecting. In: Inciardi JA, Harrison LD, editors. Drugs, health, and social policy series, Vol. 6. Heroin in the age of crack-cocaine. Thousand Oaks: Sage Publications; 1988. p. 131–59.
35.
Abelson J, Treloar C, Crawford J, Kippax S, van Beek I, Howard J. Some characteristics of early-onset injection drug users prior to and at the time of their first injection. Addiction. 2006;101(4):548–55.CrossRefPubMed
36.
Bryant J, Bryant J, Treloar C, Bryant J, Treloar C. The gendered context of initiation to injecting drug use: evidence for women as active initiates. Drug Alcohol Rev. 2007;26(3):287–93.CrossRefPubMed
37.
Chami G, Werb D, Feng C, DeBeck K, Kerr T, Wood E. Neighborhood of residence and risk of initiation into injection drug use among street-involved youth in a Canadian setting. Drug Alcohol Depend. 2013;132(3):486–90.CrossRefPubMedPubMedCentral
38.
Rahimi-Movaghar A, Amin-Esmaeili M, Shadloo B, Noroozi A, Malekinejad M. Transition to injecting drug use in Iran: a systematic review of qualitative and quantitative evidence. Int J Drug Policy. 2015;26(9):808–19.CrossRefPubMedPubMedCentral
39.
Bryant J, Treloar C. Initiators: an examination of young injecting drug users who initiate others to injecting. AIDS Behav. 2008;12(6):885–90.CrossRefPubMed
40.
Doherty MC, Edgar Monterroso MDMPH. Gender differences in the initiation of injection drug use among young adults. J Urban Health. 2000;77(3):396–414.CrossRefPubMedPubMedCentral
41.
Small W, Fast D, Krusi A, Wood E, Kerr T. Social influences upon injection initiation among street-involved youth in Vancouver, Canada: a qualitative study. Subst Abuse Treat Prev Policy. 2009;4(1):1.CrossRef
42.
Draus PJ, Carlson RG. Needles in the haystacks: the social context of initiation to heroin injection in rural Ohio. Subst Use Misuse. 2006;41(8):1111–24.CrossRefPubMed
43.
Nasir S, Rosenthal D. The social context of initiation into injecting drugs in the slums of Makassar, Indonesia. Int J Drug Policy. 2009;20(3):237–43.CrossRefPubMed
44.
Ouellet LJ, Rahimian A, Wiebel WW. The onset of drug injection among sex partners of injection drug users. AIDS Educ Prev. 1998;10(4):341.PubMed
45.
Bluthenthal RN, Wenger L, Chu D, Quinn B, Thing J, Kral AH. Factors associated with initiating someone into illicit drug injection. Drug Alcohol Depend. 2014;144:186–92.CrossRefPubMedPubMedCentral
46.
Crofts N, Louie R, Rosenthal D, Jolley D. The first hit: circumstances surrounding initiation into injecting. Addiction. 1996;91(8):1187–96.CrossRefPubMed
47.
Rotondi NK, Strike C, Kolla G, et al. Transition to injection drug use: the role of initiators. AIDS Behav. 2014;18(3):486–94.CrossRefPubMed
48.
49.
WHO. Tools to set and monitor targets for HIV prevention, diagnosis, treatment and care for key populations: Supplement to the 2014 consolidated guidelines for HIV prevention, diagnosis, treatment and care for key key populations. Geneva: World Health Organization; 2015.
50.
51.
Vashishtha D, Mittal ML, Werb D. The North American opioid epidemic: current challenges and a call for treatment as prevention. Harm Reduct J. 2017;14(1):7.CrossRefPubMedPubMedCentral
52.
53.
Mathers BM, Degenhardt L, Ali H, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375(9719):15.CrossRef
54.
Uusküla A, Rajaleid K, Talu A, Abel-Ollo K, Des Jarlais DC. A decline in the prevalence of injecting drug users in Estonia, 2005–2009. Int J Drug Policy. 2013;24(4):312–8.CrossRefPubMedPubMedCentral
55.
Genberg BL, Gange SJ, Go VF, Celentano DD, Kirk GD, Mehta SH. Trajectories of injection drug use over 20 years (1988-2008) in Baltimore, Maryland. Am J Epidemiol. 2011;173(7):829–36.CrossRefPubMedPubMedCentral
56.
Kolla G, Strike C, Roy É, et al. Initiation stories: an examination of the narratives of people who assist with a first injection. Subst Use Misuse. 2015;50:1–9.CrossRef
57.
Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Pub Health. 1996;86(5):655.CrossRef
58.
Small W, Wood E, Tobin D, Rikley J, Lapushinsky D, Kerr T. The injection support team: a peer-driven program to address unsafe injecting in a Canadian setting. Subst Use Misuse. 2012;47(5):491–501.CrossRefPubMed
59.
Werb D, Mills EJ, DeBeck K, Kerr T, Montaner JSG, Wood E. The effectiveness of anti-illicit-drug public-service announcements: a systematic review and meta-analysis. J Epidemiol Commun Health. 2011;65:7.CrossRef
60.
West S, O'Neal K. Project D.A.R.E. outcome effectiveness revisited. Am J Pub Health. 2004;94(6):1027.CrossRef
61.
Rhodes T, Bivol S, Scutelniciuc O, Hunt N, Bernays S, Busza J. Narrating the social relations of initiating injecting drug use: transitions in self and society. Int J Drug Policy. 2011;22(6):445–54.CrossRefPubMed
62.
63.
64.
Degenhardt L, Mathers BM, Wirtz AL, et al. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010–2012? A review of the six highest burden countries. Int J Drug Policy. 2014;25(1):53–60.CrossRefPubMed
65.
WHO. Antiretroviral treatment as prevention (TasP) of HIV and TB: 2012 update. Geneva: World Health Organization; 2012.
Metadata
Title
Preventing Injection Drug use Initiation: State of the Evidence and Opportunities for the Future
Authors
Dan Werb
R. N. Bluthenthal
G. Kolla
C. Strike
A. H. Kral
A. Uusküla
D. Des Jarlais
Publication date
01-02-2018
Publisher
Springer US
Published in
Journal of Urban Health / Issue 1/2018
Print ISSN: 1099-3460
Electronic ISSN: 1468-2869
DOI
https://doi.org/10.1007/s11524-017-0192-8

Other articles of this Issue 1/2018

Journal of Urban Health 1/2018 Go to the issue

OriginalPaper

High-Risk Geographic Mobility Patterns among Young Urban and Suburban Persons who Inject Drugs and their Injection Network Members

OriginalPaper

How Many Transgender Men Are There in San Francisco?

OriginalPaper

Sexual Risks and Policing among Male Migrant and Non-migrant Market Vendors in Central Asia

OriginalPaper

The Costly Consequences of not Being Socially and Behaviorally Ready to Learn by Kindergarten in Baltimore City

Brief Report

Prevalence of Sexual Violence and its Association with Depression among Male and Female Patients with Risky Drug Use in Urban Federally Qualified Health Centers

OriginalPaper

Non-injection Drug Use and Injection Initiation Assistance among People Who Inject Drugs in Tijuana, Mexico